Navigation Links
Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
Date:3/25/2009

PT. RICHMOND, Calif., March 25 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced the appointment of Joseph T. Kennedy to the position of Vice President, General Counsel and Secretary. In this role, Mr. Kennedy will provide legal advice to the company on matters including business development, corporate governance, public company and pharmaceutical industry compliance, intellectual property, and general corporate matters.

"On behalf of the Board of Directors, I am pleased to welcome Joe to the Transcept team as our General Counsel," said Glenn A. Oclassen, President & Chief Executive Officer. "Joe's broad experience and demonstrated record of achievement in the legal field and life science industry make him a valuable addition to the Transcept team as we prepare, subject to FDA approval, for the potential 2010 launch of our lead product candidate, Intermezzo(R), for patients who awaken in the middle of the night and have difficulty returning to sleep."

"I am delighted to join the Transcept management team at such an exciting time in the company's development," said Mr. Kennedy. "I am confident that the combination of seasoned management team, unique potential product opportunities and an entrepreneurial culture will make the company a success."

Mr. Kennedy has over 15 years of legal experience representing large pharmaceutical companies, developing life science companies, investment banks and venture capital firms. Mr. Kennedy served as Vice President and Acting Chief Legal Officer and previously, Chief Corporate Counsel, of Eyetech Pharmaceuticals. His work at Eyetech included
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
2. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
3. Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
4. Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
5. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
7. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
8. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
11. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancesavings.biz has ... insurance plans are cheaper during Spring. , ... auto insurance plan. Drivers should make sure they compare ... their vehicles. Clients can learn more about Spring car ... , Auto insurance quotes are becoming more and ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining how ... , Clients can review important auto insurance quotes online, ... important advantages for clients who need affordable financial security ... have coverage for their vehicles can purchase a policy ... Many agencies offer important discounts and drivers can learn ...
(Date:4/18/2015)... In the past few weeks, TheBeautyPlace.com has ... "We had to run maintenance on our shipping facilities ... Ramirez, the PR Director. "It disrupted our regular shipping ... are back on track after having completed the maintenance." ... phone systems which has not allowed some calls to ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 PHOENIX, ARIZONA ... County, along with 11 other secure destruction professionals across ... Destruction Specialists (CSDS). He will now display “CSDS” as ... were offered before the National Association of Information Destruction ... and another Grapevine, Texas. Of the 20 people who ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 ERGO-Pedic Products, ... is introducing two new products to help a broader ... back pain relief are the second most common visitors ... first product, designed specifically to help relieve sitting pain. ... Cushion, and thousands of happy customers later, we began ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2
... suggests it could show who will respond best to ... -- Genetic differences might explain why some multiple sclerosis ... an international study. , Starting with 206 southern European ... the disease, the researchers compared the DNA of patients ...
... enhancements in key genes connected to the p53 regulatory ... by creating additional safeguards in human genes to boost ... could cause cancer or a variety of genetic diseases, ... Hospital Medical Center writes in the Jan. 22 Proceedings ...
... a,statement by Reverend Carlton W. Veazey, President and CEO ... 35th anniversary of Roe v. Wade, our country is ... be safe, legal, and available,if and when it is ... the ,fetal personhood, initiatives and outright abortion bans,being promoted ...
... Inc, (TSX:,DAX) (NASDAQ: DRAX ) has received approval ... Normal Course Issuer Bid (NCIB) to,purchase up to 4,072,054 ... shares in the public float as at January 14, ... DRAXIS were issued and,outstanding., Purchases may begin on ...
... Ross J. Horsburgh Brings 20 Years of Pharmaceutical and CRO ... in Asia/Pacific Region to Key Leadership Role, ... a,leading, global full-service clinical research organization (CRO), today,announced Dr. Ross ... Development - Asia/Pacific. In this role, he will lead the,company,s ...
... be treated with Traditional Chinese medicine (TCM). Some say ... a research group in China had found TCM can ... suppress tumor cell growth and regulate tumor cell invasion ... 7, 2008 in the World Journal of Gastroenterology ...
Cached Medicine News:Health News:DNA Analysis Could Help Customize Treatments for MS 2Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 2Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 3Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 4Health News:Statement of the Reverend Carlton W. Veazey, President and CEO of the Religious Coalition for Reproductive Choice, on the 35th Anniversary of Roe v. Wade 2Health News:DRAXIS Share Buyback Approved by TSX 2Health News:DRAXIS Share Buyback Approved by TSX 3Health News:DRAXIS Share Buyback Approved by TSX 4Health News:Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion 2Health News:Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion 3Health News:How does Fu-Zheng-Jie-Du-Decoction act on PTEN expression in hepatocellular carcinoma? 2
(Date:4/17/2015)... -- Over the next five years, the marijuana industry in the ... that 14 more states will legalize recreational marijuana and two ... legal cannabis grew 74 percent in 2014 to $2.7 billion, ... could grow more than fourfold to $11 billion in the ... marijuana. Cannabiz Mobile Inc. (OTCBB: LGBI) is a ...
(Date:4/17/2015)... 16, 2015 Research and Markets ( ... "Corporate Reputation of Pharma in 2014 - a Perspective ... to their offering. This independent study, funded ... groups with an interest in diabetes on the corporate ... pharma industry as a whole) in 2014. The results ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ) has announced ... in 2014 - a Perspective of Mental Health Patient ... For the first time, in 2014, the ... the pharmaceutical industry held by patient groups with an ... organisations representing all therapy areas. - Findings ...
Breaking Medicine Technology:Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
... Novo Software™, a leading provider of flow cytometry data ... cytometry instruments and reagents, announced today an agreement whereby ... FCS Express™ – to customers in clinical, research and ... FCS Express with every CyFlow® Cube instrument and resell ...
... (OTC Bulletin Board: NEPH ) announced that it ... Administration ("FDA") of the 510(k) application for marketing clearance of ... Nephros submitted a new 510(k) application to market its hemodiafiltration ... Nephros received the initial FDA review of its new 510(k) ...
Cached Medicine Technology:Partec to Distribute FCS Express 4 Flow Cytometry with CyFlow Cube™ Instruments 2Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System 2Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System 3Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: